Implantable cardiovascular electronic devices are now an essential part of clinical practice in cardiology. The presence in a large number of adult population of problems in the electrical conduction system and several indications with multiple comorbidities has led to an increase in use of implantable cardiovascular electronic devices. However, the application benefit of these devices has been affected by the higher incidence of infections, which represent a serious complication that can lead to significant morbidity, mortality and cost for health centers due to antibiotic treatments, device replacement and longer hospitalization times. For this reason, the present analysis is oriented to possibility of reducing the dissemination of Staphylococcus Aureus by evaluating different techniques for adsorption of a vancomycin antibiotic film in implantable cardiovascular electronic devices. Through this analysis it is possible to establish a new alternative prophylactic method to avoid risks to the health of patients who have problems in the electrical conduction system, which are prone to becoming infected by Staphylococcus Aureus strains during the implantation of the device; in this way, infection can be controlled locally without requiring removal of the initial device and thus avoid an intracardiac compromise that leads to major complications such as endocarditis.